Literature DB >> 10648428

DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection.

M H Vogt1, R A de Paus, P J Voogt, R Willemze, J H Falkenburg.   

Abstract

Graft rejection after histocompatibility locus antigen (HLA)-identical stem cell transplantation results from the recognition of minor histocompatibility antigens on donor stem cells by immunocompetent T lymphocytes of recipient origin. T-lymphocyte clones that specifically recognize H-Y epitopes on male target cells have been generated during graft rejection after sex-mismatched transplantation. Previously, 2 human H-Y epitopes derived from the same SMCY gene have been identified that were involved in bone marrow graft rejection. We report the identification of a new male-specific transplantation antigen encoded by the Y-chromosome-specific gene DFFRY. The DFFRY-derived peptide was recognized by an HLA-A1 restricted CTL clone, generated during graft rejection from a female patient with acute myeloid leukemia who rejected HLA-phenotypically identical bone marrow from her father. The identification of this gene demonstrates that at least 2 genes present on the human Y-chromosome code for male-specific transplantation antigens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648428

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

Review 1.  Role of the AZFa candidate genes in male infertility.

Authors:  C Foresta; E Moro; A Rossi; M Rossato; A Garolla; A Ferlin
Journal:  J Endocrinol Invest       Date:  2000-11       Impact factor: 4.256

2.  Expanding the immunotherapeutic potential of minor histocompatibility antigens.

Authors:  Eric Spierings; Els Goulmy
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

3.  Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.

Authors:  David B Miklos; Haesook T Kim; Katherine H Miller; Luxuan Guo; Emmanuel Zorn; Stephanie J Lee; Ephraim P Hochberg; Catherine J Wu; Edwin P Alyea; Corey Cutler; Vincent Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

4.  The H-Y Antigen in Embryonic Stem Cells Causes Rejection in Syngeneic Female Recipients.

Authors:  Xiaomeng Hu; Simon T Kueppers; Nigel G Kooreman; Alessia Gravina; Dong Wang; Grigol Tediashvili; Stephan Schlickeiser; Marco Frentsch; Christos Nikolaou; Andreas Thiel; Sivan Marcus; Sigrid Fuchs; Joachim Velden; Hermann Reichenspurner; Hans-Dieter Volk; Tobias Deuse; Sonja Schrepfer
Journal:  Stem Cells Dev       Date:  2020-08-25       Impact factor: 3.272

5.  Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.

Authors:  Fabrice Porcheray; David B Miklos; Blair H Floyd; Stefanie Sarantopoulos; Roberto Bellucci; Robert J Soiffer; Joseph H Antin; Edwin P Alyea; Jerome Ritz; Emmanuel Zorn
Journal:  Transplantation       Date:  2011-08-15       Impact factor: 4.939

Review 6.  Clinical impact of H-Y alloimmunity.

Authors:  Rakesh Popli; Bita Sahaf; Hideki Nakasone; Joyce Yeuk Yu Lee; David B Miklos
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

7.  Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease.

Authors:  Anandharaman Veerapathran; Joseph Pidala; Francisca Beato; Brian Betts; Jongphil Kim; Joel G Turner; Marc K Hellerstein; Xue-Zhong Yu; William Janssen; Claudio Anasetti
Journal:  Blood       Date:  2013-08-01       Impact factor: 22.113

8.  Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.

Authors:  David B Miklos; Haesook T Kim; Emmanuel Zorn; Ephraim P Hochberg; Luxuan Guo; Alex Mattes-Ritz; Sebastien Viatte; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

9.  DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells.

Authors:  Kellie V Rosinski; Nobuharu Fujii; Jeffrey K Mito; Kevin K W Koo; Suzanne M Xuereb; Olga Sala-Torra; James S Gibbs; Jerald P Radich; Yoshiki Akatsuka; Benoît J Van den Eynde; Stanley R Riddell; Edus H Warren
Journal:  Blood       Date:  2008-02-25       Impact factor: 22.113

10.  Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants.

Authors:  Stephen Spellman; Melissa B Warden; Michael Haagenson; Bradley C Pietz; Els Goulmy; Edus H Warren; Tao Wang; Thomas M Ellis
Journal:  Biol Blood Marrow Transplant       Date:  2009-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.